Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateTimeSourceHeadlineSymbolCompany
03/08/200909:35Dow Jones NewsRoche Gains US Nod For Avastin In Kidney Cancer; Market CrowdedNASDAQ:ONXXOnyx Pharmaceuticals Inc.
29/07/200921:00PR Newswire (US)Onyx Pharmaceuticals Announces Second Quarter 2009 Financial Results Teleconference and WebcastNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/07/200911:04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/07/200918:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/07/200918:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/07/200918:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/07/200914:54Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/07/200911:58MarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on SBIB, AFFX, FINL, SSRI, IACI and ONXXNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
23/07/200913:30MarketwiredMarket Pulse Breaking News Alert for Thursday, July 23, 2009: ARYC -- Arrayit Corporation Announces Worldwide Product Sales Up NNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
22/07/200913:42Dow Jones NewsBayer:Positive Data From Nexavar Phase II Trial In Breast CancerNASDAQ:ONXXOnyx Pharmaceuticals Inc.
22/07/200913:16DPA AFX NachrichtenBayer macht Fortschritte bei Krebsmittel Nexavar bei BrustkrebsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
22/07/200913:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
22/07/200913:00PR Newswire (US)Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast CancerNASDAQ:ONXX
13/07/200912:31MarketwiredTheFortuneFinancial.com Free Market Research on WCRX, STAR, CMED, ACXM, EWBC and ONXXNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/07/200917:05Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/06/200923:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/06/200913:27MarketwiredBenchmarkJournal.com Free Analyst Review for BPFH, CBSH, ONXX, EWBC, CPSL and RNWKNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/06/200914:36DPA AFX NachrichtenBayer startet abschließende klinische Studie mit Nexavar gegen LungenkrebsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
18/05/200907:14DPA AFX NachrichtenAktien Frankfurt Ausblick: Verluste - Schwache Vorgaben belastenNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
18/05/200908:54DPA AFX NachrichtenROUNDUP/Aktien Frankfurt Eröffnung: DAX dämmt Auftaktverluste einNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/06/200921:10PR Newswire (US)Onyx Pharmaceuticals to Present at the Goldman Sachs 30th Annual Global Healthcare ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/06/200914:40Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/06/200913:39Dow Jones NewsBayer, Onyx Start Phase III Trial Of Nexavar For Lung CancerNASDAQ:ONXXOnyx Pharmaceuticals Inc.
01/06/200913:00PR Newswire (US)Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
30/05/200922:07Dow Jones NewsUPDATE:Roche's Avastin Fails In Early Colon Cancer, Dims HopeNASDAQ:ONXXOnyx Pharmaceuticals Inc.
30/05/200920:24Dow Jones NewsUPDATE:Roche's Avastin Fails In Early Colon Cancer, Dims HopeNASDAQ:ONXXOnyx Pharmaceuticals Inc.
30/05/200914:30Dow Jones NewsRoche's Avastin Shows No Benefit In Early Colon Cancer- StudyNASDAQ:ONXXOnyx Pharmaceuticals Inc.
28/05/200913:00PR Newswire (US)Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/05/200919:11Dow Jones NewsCancer Meeting Brings Avastin Data, Lung Cancer InsightsNASDAQ:ONXXOnyx Pharmaceuticals Inc.
27/05/200919:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX